Literature DB >> 8817111

Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients.

K A Earle1, M Mishra, A Morocutti, D Barnes, E Stephens, J Chambers, G C Viberti.   

Abstract

Insulin-dependent diabetic (IDDM) subjects with microalbuminuria have an increased long-term risk of overt cardiovascular disease; however, the early exposure to cardiovascular risk factors may increase their predisposition to current silent myocardial ischaemia. The frequency of silent myocardial ischaemia detected by stress echocardiography and electrocardiography was significantly greater in 32 asymptomatic IDDM patients with microalbuminuria compared to 32 normoalbuminuric IDDM patients (25% [n = 8] vs 6.3% [n = 2]; p = 0.03, odds ratio [95% CI] 6.3 [1.2, 37.8]). Elective coronary artery bypass grafting was required in 1 patient with microalbuminuria and silent myocardial disease. Microalbuminuria and poorer autonomic function were independently associated with silent myocardial ischaemia in multivariate analysis (p = 0.03 and p = 0.02, respectively). Screening for silent myocardial ischaemia using these non-invasive tests may be warranted in microalbuminuric IDDM which patients could be of considerable clinical importance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817111     DOI: 10.1007/s001250050520

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

1.  High Normal Urinary Albumin-Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study.

Authors:  Jie Wang; Yun Wang; Yijun Li; Ying Hu; Lingzi Jin; Weiqing Wang; Zhengnan Gao; Xulei Tang; Li Yan; Qin Wan; Zuojie Luo; Guijun Qin; Lulu Chen; Weijun Gu; Zhaohui Lyv; Yiming Mu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-20       Impact factor: 6.055

2.  The association of silent coronary artery disease and metabolic syndrome in Chinese with type 2 diabetes mellitus.

Authors:  Jack C-R Tsai; Dao-Ming Chang; Fu-Mei Chung; Jung-Chou Wu; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2004-05-10

Review 3.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria.

Authors:  M K Rutter; J M McComb; S Brady; S M Marshall
Journal:  Clin Auton Res       Date:  1998-10       Impact factor: 4.435

Review 5.  Management of diabetic renal disease.

Authors:  Cecil Eboh; Tahseen A Chowdhury
Journal:  Ann Transl Med       Date:  2015-07

6.  Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria.

Authors:  Ana Chico; Antoni Tomás; Anna Novials
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

7.  Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Pietro Fratino
Journal:  Cardiovasc Diabetol       Date:  2002-11-22       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.